Globitair

GLP-1 Demand Boosts Dis-Chem’s South Africa Pharmacy Revenue

Bloomberg MarketsSouth Africa

Dis-Chem Pharmacies Ltd. said surging demand for GLP-1 medicines is helping drive double-digit growth in its dispensary revenue as South Africans increasingly turn to the expensive drugs used to treat diabetes and obesity.

Read the full story at Bloomberg MarketsOpen in the live monitor

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More news about South Africa